Please assess the completion status of the following clinical trial:

Trial Title: 13-valent Pneumococcal Conjugate Vaccine Study in Adults => 50 Years of Age in Mexico

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female older than 50 years of age~* Eligibility must be determined by medical history, physical exam and clinical judgment~* Able to complete an electronic diary~* Available for duration of study~* Negative pregnancy test for subjects in group 2 age 50 to 64 years~* Practice abstinence or use reliable birth control if age is 50 to 64 years~Exclusion Criteria:~* History of allergic reaction to any vaccine~* Previous vaccination with licensed or experimental pneumococcal vaccine~* S. pneumonia infection within past 5 years before investigational product administration~* Known or suspected immunodeficiency or received treatment including cytotoxic agents or systemic corticosteroids, serious chronic disorder such as malignancy cancer~* Receipt of plasma products or immunoglobulins within 60 days~* Bleeding conditions or diathesis~* Receipt of investigational product within 28 days before study entry~* Other severe acute or chronic medical or psychiatric condition

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Group 1 (Type: EXPERIMENTAL): =\> 65 years of age
- Group 2 (Type: EXPERIMENTAL): 50 to 64 years of age

Based on this trial design, predict the completion outcome and termination type (if applicable).